trending Market Intelligence /marketintelligence/en/news-insights/trending/5E0Iz2i2mrQxH9ROe8XNnA2 content esgSubNav
In This List

Impax Laboratories names CEO

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Impax Laboratories names CEO

Impax Laboratories Inc. appointed Paul Bisaro as the company's president and CEO, replacing J. Kevin Buchi, who had been serving in the positions on an interim basis.

Bisaro, the former executive chairman of Allergan PLC, will also join the Impax board. Bisaro continues to serve on the Allergan board.